SERA
Sera Prognostics, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$2.03-0.98%
Price as of Jul 20, 2026
SERA capital
Sera Prognostics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.04x
- Net debt / equity
- -0.02x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.08x
- Net debt / EBITDA
- 0.05x
Liquidity & coverage
- Current ratio
- 2.12x
- Quick ratio
- 2.12x
- Cash ratio
- 2.02x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $26.3M
Cash & dividend
- FCF / debt
- -11.01x
- Cash flow / debt
- -10.72x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.